Business
Maven said the acquisition of Naytal will accelerate its growth in the U.K. and Europe.
The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.
Ida Tin, cofounder and chairwoman at Clue, explains how she sees the fall of Silicon Valley Bank affecting femtech investments and how the sector could progress fruitfully.
VC funding in the world's second-biggest digital health ecosystem decreased by 41% year-on-year.
Without a transaction, the prescription digital therapeutics company said it may need to reorganize or liquidate.
Zus also announced a partnership with primary care tech company Elation Health.
The company also announced a new payer network and revenue cycle management service.
Fertility care is expensive and often hard to access. OCA Ventures' Dana Sun and Ellen Bursey explain the digital health landscape and offer advice for investors and founders in the space.
Also, Intellect has secured undisclosed investment from IHH Healthcare for its regional expansion.
The funds will be used to accelerate the adoption of the platform's applied behavior analysis-focused tools.